Skip to main content
Top
Published in: Abdominal Radiology 2/2009

01-04-2009

Assessment of the extension and the inflammatory activity in Crohn’s disease: comparison of ultrasound and MRI

Authors: María J. Martínez, Tomás Ripollés, José M. Paredes, Esther Blanc, Luis Martí-Bonmatí

Published in: Abdominal Radiology | Issue 2/2009

Login to get access

Abstract

Objective

The purpose of this prospective study was twofold: to examine the efficacy of MRI and sonography in the assessment of Crohn’s disease (CD) activity in comparison with clinical scoring and biologic tests and to compare both techniques in the evaluation of extension and transmural complications.

Material and methods

Thirty patients with histologically proven Crohn’s disease were prospectively examined the same day first with sonography and after MRI. Sonographic exam included evaluation of bowel wall thickness, vascularity pattern, and perienteric changes. Thirty minutes prior to MRI imaging, patients were given 250 mL of dilute sodium phosphate solution and additional 750 mL of water orally. MRI images evaluation included bowel wall thickening, bowel wall enhancement, and perienteric changes. The gastrointestinal tract was divided into five segments. Findings and extension of the both techniques were verified by means of barium studies, surgery, or/and colonoscopy. The sonographic and MR findings were compared with clinical and laboratory data.

Results

About 53 of 119 (45%) bowel segments showed pathological changes in gold standard tests. Sonography was superior to MRI in the localization of affected bowel segments (sensitivity: US 91%; MRI 83%; intertechniques agreement, kappa: 0.905) and in recognizing transmural complications (sensitivity: US 80%; MRI 72%), although significant differences were not found (p > 0.05). A statistically significant correlation between color Doppler flow and MR bowel wall enhancement (segment-by-segment analysis and per patient analysis; p > 0.5), and between perienteric changes in both techniques (p > 0.5) were found. Wall thickness measured on sonography was significantly greater in the group of patients with clinical activity (p = 0.023) or with clinical-biologic activity (p = 0.024). Grades of hyperemia and MR contrast enhancement of patients with clinical–biologic activity was higher than in patients without clinical–biologic activity (p = 0.019; p = 0.023).

Conclusion

In summary, both ultrasound and MRI are sensitive to localize the affected bowel segments and to detect transmural complications in patients with Crohn’s disease. A significant correlation between color Doppler flow and bowel wall enhancement on MRI was found. Sonographic wall thickness, color Doppler flow, and bowel wall enhancement on MRI are related with clinical or biologic activity.
Literature
1.
go back to reference Stange EF, Travis SP, Vermeire S, et al. (2006) European Crohn’s and Colitis organization (ECCO). European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis Gut 55:1–15CrossRef Stange EF, Travis SP, Vermeire S, et al. (2006) European Crohn’s and Colitis organization (ECCO). European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis Gut 55:1–15CrossRef
2.
go back to reference Gasche C, Moser G, Turetschek K, Schober E, Moeschl P, Oberhuber G (1999) Transabdominal bowel sonography for the detection of intestinal complications in Crohn’s disease Gut 44:112–117PubMedCrossRef Gasche C, Moser G, Turetschek K, Schober E, Moeschl P, Oberhuber G (1999) Transabdominal bowel sonography for the detection of intestinal complications in Crohn’s disease Gut 44:112–117PubMedCrossRef
3.
go back to reference Valette PJ, Rioux M, Pilleul F, Saurin JC, Fouque P, Henry L (2001) Ultrasonography of chronic inflammatory bowel disease Eur Radiol 11:1859–1866PubMedCrossRef Valette PJ, Rioux M, Pilleul F, Saurin JC, Fouque P, Henry L (2001) Ultrasonography of chronic inflammatory bowel disease Eur Radiol 11:1859–1866PubMedCrossRef
4.
go back to reference Maconi G, Sampietro GM, Parente F, Pompili G, Russo A, Cristaldi M, et al. (2003) Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn’s disease: a prospective comparative study Am J Gastroenterol 98:1545–1555PubMedCrossRef Maconi G, Sampietro GM, Parente F, Pompili G, Russo A, Cristaldi M, et al. (2003) Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn’s disease: a prospective comparative study Am J Gastroenterol 98:1545–1555PubMedCrossRef
5.
go back to reference Potthast S, Rieber A, von Tirpitz C, Wruk D, Adler G, Brambs HJ (2002) Ultrasound and magnetic resonance imaging in Crohn’s disease: a comparison Eur Radiol 12:1416–1422PubMedCrossRef Potthast S, Rieber A, von Tirpitz C, Wruk D, Adler G, Brambs HJ (2002) Ultrasound and magnetic resonance imaging in Crohn’s disease: a comparison Eur Radiol 12:1416–1422PubMedCrossRef
6.
go back to reference Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. (2002) MR enteroclysis: technical considerations and clinical applications Eur Radiol 12:2651–2658PubMed Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. (2002) MR enteroclysis: technical considerations and clinical applications Eur Radiol 12:2651–2658PubMed
7.
go back to reference Best WR, Becktel JM, Singleton JW, Kern FJ (1976) Development of a Crohn’s disease activity index: national cooperative Crohn’s disease study Gastroenterology 70:439–444PubMed Best WR, Becktel JM, Singleton JW, Kern FJ (1976) Development of a Crohn’s disease activity index: national cooperative Crohn’s disease study Gastroenterology 70:439–444PubMed
8.
go back to reference Maccioni F, Viscido A, Broglia L, Marrollo M, Masciangelo R, Caprilli R, et al. (2000) Evaluation of Crohn disease activity with magnetic resonance imaging Abdom Imaging 25:219–228PubMedCrossRef Maccioni F, Viscido A, Broglia L, Marrollo M, Masciangelo R, Caprilli R, et al. (2000) Evaluation of Crohn disease activity with magnetic resonance imaging Abdom Imaging 25:219–228PubMedCrossRef
9.
go back to reference Fraquelli M, Colli A, Casazza G, Paggi S, Colucci A, Massironi S, et al. (2005) Role of US in detection of Crohn disease: meta-analysis Radiology 236:95–101PubMedCrossRef Fraquelli M, Colli A, Casazza G, Paggi S, Colucci A, Massironi S, et al. (2005) Role of US in detection of Crohn disease: meta-analysis Radiology 236:95–101PubMedCrossRef
10.
go back to reference Spalinguer J, Patriquin H, Miron MC, Marx G, Herzog D, Dubois J, et al. (2000) Doppler US in patients with Crohn disease: vessel density in the diseased bowel reflects disease activity Radiology 217:787–791 Spalinguer J, Patriquin H, Miron MC, Marx G, Herzog D, Dubois J, et al. (2000) Doppler US in patients with Crohn disease: vessel density in the diseased bowel reflects disease activity Radiology 217:787–791
11.
go back to reference Esteban JM, Maldonado L, Sanchiz J, Minguez M, Benages A (2001) Activity of Crohn disease assessed by color Doppler ultrasound analysis of the affected loops Eur Radiol 11:1423–1428PubMedCrossRef Esteban JM, Maldonado L, Sanchiz J, Minguez M, Benages A (2001) Activity of Crohn disease assessed by color Doppler ultrasound analysis of the affected loops Eur Radiol 11:1423–1428PubMedCrossRef
12.
go back to reference Haber HP, Busch A, Ziebach R, Stern M (2000) Bowel wall thickness measured by ultrasound as a marker of Crohn’s disease activity in children Lancet 355:1239–1240PubMedCrossRef Haber HP, Busch A, Ziebach R, Stern M (2000) Bowel wall thickness measured by ultrasound as a marker of Crohn’s disease activity in children Lancet 355:1239–1240PubMedCrossRef
13.
go back to reference Haber HP, Busch A, Ziebach R, Dette S, Ruck P, Stern M (2002) Ultrasonographic findings correspond to clinical, endoscopic, and histologic findings in inflammatory bowel disease and other enterocolitides J Ultrasound Med 21:375–382PubMed Haber HP, Busch A, Ziebach R, Dette S, Ruck P, Stern M (2002) Ultrasonographic findings correspond to clinical, endoscopic, and histologic findings in inflammatory bowel disease and other enterocolitides J Ultrasound Med 21:375–382PubMed
14.
go back to reference Dubbins PA (1984) Ultrasound demonstration of bowel wall thickness in inflammatory disease Clin Radiol 35:227–231PubMedCrossRef Dubbins PA (1984) Ultrasound demonstration of bowel wall thickness in inflammatory disease Clin Radiol 35:227–231PubMedCrossRef
15.
go back to reference Ruess L, Nussbaum AR, Bulas D, Mohan P, Bader A, Latimer JS, et al. (2000) Inflammatory bowel disease in children and young adults: correlation of sonographic and clinical parameters during treatment AJR 175:79–84PubMed Ruess L, Nussbaum AR, Bulas D, Mohan P, Bader A, Latimer JS, et al. (2000) Inflammatory bowel disease in children and young adults: correlation of sonographic and clinical parameters during treatment AJR 175:79–84PubMed
16.
go back to reference Kettriz U, Isaacs K, Warshauer DM, et al. (1995) Crohn’s disease. Pilot study comparing MRI of the abdomen with clinical evaluation J Clin Gastroenterol 21(3):249–253CrossRef Kettriz U, Isaacs K, Warshauer DM, et al. (1995) Crohn’s disease. Pilot study comparing MRI of the abdomen with clinical evaluation J Clin Gastroenterol 21(3):249–253CrossRef
17.
go back to reference Madsen SM, Thomsen HS, Schlinchting P, et al. (1999) Evaluation of treatment response in active Crohn’s disease by low-field magnetic resonance imaging Abdom Imaging 24:164–166CrossRef Madsen SM, Thomsen HS, Schlinchting P, et al. (1999) Evaluation of treatment response in active Crohn’s disease by low-field magnetic resonance imaging Abdom Imaging 24:164–166CrossRef
18.
go back to reference Schunk K, Kerne A, Oberholzer K, et al. (2000) Hydro-MRI in Crohn’s disease: appraisal of disease activity Invest Radiol 35:431–437PubMedCrossRef Schunk K, Kerne A, Oberholzer K, et al. (2000) Hydro-MRI in Crohn’s disease: appraisal of disease activity Invest Radiol 35:431–437PubMedCrossRef
19.
go back to reference Koh DM, Miao Y, Chinn RJS, Amin Z, Zeegen R, Westaby D, et al. (2001) MR imaging evaluation of the activity of Crohn’s disease Am J Roentgenol 177:1325–1336 Koh DM, Miao Y, Chinn RJS, Amin Z, Zeegen R, Westaby D, et al. (2001) MR imaging evaluation of the activity of Crohn’s disease Am J Roentgenol 177:1325–1336
20.
go back to reference Miao YM, Koh DM, Amin Z, et al. (2002) Ultrasound and magnetic resonance imaging assessment of active bowel segments in Crohn’s disease Clin Radiol 57:913–918PubMedCrossRef Miao YM, Koh DM, Amin Z, et al. (2002) Ultrasound and magnetic resonance imaging assessment of active bowel segments in Crohn’s disease Clin Radiol 57:913–918PubMedCrossRef
21.
go back to reference Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. (2004) Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results Eur Radiol 14:1017–1024PubMedCrossRef Gourtsoyiannis N, Papanikolaou N, Grammatikakis J, et al. (2004) Assessment of Crohn’s disease activity in the small bowel with MR and conventional enteroclysis: preliminary results Eur Radiol 14:1017–1024PubMedCrossRef
22.
go back to reference Parente F, Greco S, Molteni M, et al. (2004) Modern imaging of Crohn’s disease using bowel ultrasound Inflamm Bowel Dis 10:452–461PubMedCrossRef Parente F, Greco S, Molteni M, et al. (2004) Modern imaging of Crohn’s disease using bowel ultrasound Inflamm Bowel Dis 10:452–461PubMedCrossRef
23.
go back to reference Maccioni F, Bruni A, Viscido A, Colaiacomo MCh, Cocco A, Montesani Ch, et al. (2006) MR imaging in patients with Crohn disease: value of T2-versus T1-weighted Galdolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent Radiology 238:517–530PubMedCrossRef Maccioni F, Bruni A, Viscido A, Colaiacomo MCh, Cocco A, Montesani Ch, et al. (2006) MR imaging in patients with Crohn disease: value of T2-versus T1-weighted Galdolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent Radiology 238:517–530PubMedCrossRef
24.
go back to reference Masselli G, Casciani E, Polettini E, Lanciotti S, Bertini L, Gualkdi G (2006) Assessment of Crohn’s disease in the small bowel: prospective comparison of magnetic resonance enteroclysis with conventional enteroclysis Eur Radiol 16:2817–2827PubMedCrossRef Masselli G, Casciani E, Polettini E, Lanciotti S, Bertini L, Gualkdi G (2006) Assessment of Crohn’s disease in the small bowel: prospective comparison of magnetic resonance enteroclysis with conventional enteroclysis Eur Radiol 16:2817–2827PubMedCrossRef
25.
go back to reference Maccioni F, Viscido A, Marini M, Caprilli R (2002) MRI evaluation of Crohn’s disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents Abdom Imaging 27:384–393PubMedCrossRef Maccioni F, Viscido A, Marini M, Caprilli R (2002) MRI evaluation of Crohn’s disease of the small and large bowel with the use of negative superparamagnetic oral contrast agents Abdom Imaging 27:384–393PubMedCrossRef
26.
go back to reference Maconi G, Parente F, Bollani S, et al. (1996) Abdominal ultrasound in the assessment of extent and activity of Crohn’s disease: clinical significance and implication of bowel wall thickening Am J Gastroenterol 91:1604–1609PubMed Maconi G, Parente F, Bollani S, et al. (1996) Abdominal ultrasound in the assessment of extent and activity of Crohn’s disease: clinical significance and implication of bowel wall thickening Am J Gastroenterol 91:1604–1609PubMed
27.
go back to reference Neye H, Voderholzer W, Rickes S, Weber J, Wermke W, Lochs H (2004) Evaluation of criteria for the activity of Crohn’s disease by power Doppler sonography Dig Dis 22:67–72PubMedCrossRef Neye H, Voderholzer W, Rickes S, Weber J, Wermke W, Lochs H (2004) Evaluation of criteria for the activity of Crohn’s disease by power Doppler sonography Dig Dis 22:67–72PubMedCrossRef
28.
go back to reference Pauls S, Gabelmann A, Schmidt SA, et al. (2006) Evaluating bowel wall vascularity in Crohn’s disease: a comparison of dynamic MRI and wideband harmonic imaging contrast-enhanced low MI ultrasound Eur Radiol 16:2410–2417PubMedCrossRef Pauls S, Gabelmann A, Schmidt SA, et al. (2006) Evaluating bowel wall vascularity in Crohn’s disease: a comparison of dynamic MRI and wideband harmonic imaging contrast-enhanced low MI ultrasound Eur Radiol 16:2410–2417PubMedCrossRef
29.
go back to reference Florie J, Wasser MN, Arts-Cieslik K, et al. (2006) Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn’s disease Am J Roentgenol 186:1384–1392CrossRef Florie J, Wasser MN, Arts-Cieslik K, et al. (2006) Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn’s disease Am J Roentgenol 186:1384–1392CrossRef
30.
go back to reference Ajaj WM, Lauenstein TC, Pelster G, Gerken G, Ruehm SG, Debatin JF, et al. (2005) Magnetic resonance colonography for the detection of inflammatory disease of the large bowel: quantifying the inflammatory activity Gut 54:257–263PubMedCrossRef Ajaj WM, Lauenstein TC, Pelster G, Gerken G, Ruehm SG, Debatin JF, et al. (2005) Magnetic resonance colonography for the detection of inflammatory disease of the large bowel: quantifying the inflammatory activity Gut 54:257–263PubMedCrossRef
31.
go back to reference Sempere GA, Martinez Sanjuán V, Medina Chulea, et al. (2005) MRI evaluation of inflammatory activity in Crohn’s disease Am J Roentgenol 184:1829–1835 Sempere GA, Martinez Sanjuán V, Medina Chulea, et al. (2005) MRI evaluation of inflammatory activity in Crohn’s disease Am J Roentgenol 184:1829–1835
Metadata
Title
Assessment of the extension and the inflammatory activity in Crohn’s disease: comparison of ultrasound and MRI
Authors
María J. Martínez
Tomás Ripollés
José M. Paredes
Esther Blanc
Luis Martí-Bonmatí
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 2/2009
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-008-9365-y

Other articles of this Issue 2/2009

Abdominal Radiology 2/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.